NCT04076618

Brief Summary

The main goal of the proposed study is to compare the effects of weight loss (WL) alone with WL plus weighted vest use or WL plus resistance exercise training (RT) on indicators of bone health and subsequent fracture risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 3, 2019

Completed
11 months until next milestone

Study Start

First participant enrolled

August 12, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
10 months until next milestone

Results Posted

Study results publicly available

February 6, 2025

Completed
Last Updated

February 6, 2025

Status Verified

April 1, 2024

Enrollment Period

3.6 years

First QC Date

August 29, 2019

Results QC Date

January 15, 2025

Last Update Submit

January 15, 2025

Conditions

Keywords

nutritionvest

Outcome Measures

Primary Outcomes (1)

  • Change in Total Hip Trabecular Volumetric Bone Mineral Density (vBMD)

    measured in mg/cm3 during computed tomography (CT) scan

    12 months from baseline

Secondary Outcomes (19)

  • Change in Total Hip Trabecular Volumetric Bone Mineral Density (vBMD)

    6 months from baseline

  • Change in Femoral Neck Volumetric Bone Mineral Density (vBMD)

    6 months from baseline

  • Change in Femoral Neck Volumetric Bone Mineral Density (vBMD)

    12 months from baseline

  • Change in Lumbar Spine Volumetric Bone Mineral Density (vBMD)

    6 months from baseline

  • Change in Lumbar Spine Volumetric Bone Mineral Density (vBMD)

    12 months from baseline

  • +14 more secondary outcomes

Other Outcomes (23)

  • Mid-thigh Muscle Density Measured in Hounsfield Units (HU)

    12 months from baseline

  • Mid- Thigh Intermuscular Fat Cross Sectional Area (CSA) (cm2)

    12 months from baseline

  • Cortical Thickness (mm)

    12 months from baseline

  • +20 more other outcomes

Study Arms (3)

Weight Loss plus Vest

EXPERIMENTAL
Device: VestBehavioral: weight loss program

Weight Loss Plus Resistance Exercise Training

ACTIVE COMPARATOR
Behavioral: Resistance Exercise TrainingBehavioral: weight loss program

Weight Loss

ACTIVE COMPARATOR
Behavioral: weight loss program

Interventions

VestDEVICE

Weighted Vest worn \> or = 8 hours per day

Weight Loss plus Vest

Structured exercise training 3 days a week

Weight Loss Plus Resistance Exercise Training

a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)

Weight LossWeight Loss Plus Resistance Exercise TrainingWeight Loss plus Vest

Eligibility Criteria

Age60 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60-85 years
  • BMI=30-40 kg/m\^2 or BMI 27.0-\<30.0 kg/m\^2 plus one risk factor
  • Weight stability - no weight loss \> 5% in past 6 months
  • No contraindications for safe and optimal participation in exercise training/vest use.
  • Approved for participation by Study Coordinator
  • Willing to provide informed consent; agree to all study procedures and assessments; Able to provide own transit to assessment/intervention visits
  • Willing to complete online/electronic study forms and participate in virtual group sessions, as needed.

You may not qualify if:

  • Weight greater than 450 lbs
  • Dependent on cane or walker: \>2 falls (injurious on non-injurious) in past year
  • Any contraindications for participation in voluntary weight loss
  • Smoker (\>1 cigarette/d or 4/wk within yr); Excessive alcohol use (\>14 drinks/wk)
  • Participation in regular resistance training and/or high intensity/high impact aerobic exercise for \>60 mins per day on \> 5 days/week for the past 6 months
  • Evidence of cognitive impairment (MoCA\<20)
  • Osteoporosis (self-report and on prescription medication, T-score \< or = -2.5 on total hip, femoral neck, lumbar spine or distal radius scan at screening visit, or fracture risk assessment tool (FRAX) 10-year risk scores \>3% for hip fracture or \>20% for major osteoporotic fracture (TBS adjusted FRAX is preferable if available)
  • Self-reported prior spine, hip, wrist, or shoulder fracture after age 40 (except when caused by trauma or fall from height)
  • Chronic back/shoulder/knee pain with current or past (within 1 year) prescription medication use for at least 3 months
  • Severe, diagnosed arthritis (osteoarthritis, rheumatoid arthritis, or gout) with current or past (within 1 year) prescription medication use for at least 3 months
  • Past (ever) or planned (next 12 months) back surgery
  • Past (6 months prior) or planned (next 12 months) joint replacement surgery; or past (ever) unilateral or bilateral hip replacement surgery
  • Past (ever) metal device or fixation in the hip, pelvis, or femur
  • Uncontrolled hypertension (BP \> 160/90 mmHg)
  • Current or recent past (within 1 year) severe symptomatic heart disease, uncontrolled angina, stroke, chronic respiratory disease requiring oxygen, neurological or hematological disease requiring treatment for at least 3 months in past year
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest University School of Medicine

Winston-Salem, North Carolina, 27157, United States

Location

Related Publications (3)

  • Beavers KM, Lynch SD, Fanning J, Howard M, Lawrence E, Lenchik L, Shapses SA, Weaver AA, Wherry SJ, Zamora Z, Nicklas BJ, Beavers DP. Weighted Vest Use or Resistance Exercise to Offset Weight Loss-Associated Bone Loss in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2025 Jun 2;8(6):e2516772. doi: 10.1001/jamanetworkopen.2025.16772.

  • Beavers KM, Avery AE, Shankaran M, Evans WJ, Lynch SD, Dwyer C, Howard M, Beavers DP, Weaver AA, Lenchik L, Cawthon PM. Application of the D3 -creatine muscle mass assessment tool to a geriatric weight loss trial: A pilot study. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2350-2358. doi: 10.1002/jcsm.13322. Epub 2023 Sep 5.

  • Miller RM, Beavers DP, Cawthon PM, Crotts C, Fanning J, Gerosa J, Greene KA, Hsieh KL, Kiel J, Lawrence E, Lenchik L, Lynch SD, Nesbit BA, Nicklas BJ, Weaver AA, Beavers KM. Incorporating Nutrition, Vests, Education, and Strength Training (INVEST) in Bone Health: Trial Design and Methods. Contemp Clin Trials. 2021 May;104:106326. doi: 10.1016/j.cct.2021.106326. Epub 2021 Feb 22.

MeSH Terms

Conditions

Weight Loss

Interventions

Resistance TrainingWeight Reduction Programs

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth PromotionHealth EducationPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Kristen Beavers, PhD, MPH, RD
Organization
Wake Forest University School of Medicine

Study Officials

  • Kristen Beavers, PhD, MPH, RD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2019

First Posted

September 3, 2019

Study Start

August 12, 2020

Primary Completion

April 1, 2024

Study Completion

April 1, 2024

Last Updated

February 6, 2025

Results First Posted

February 6, 2025

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations